Trial Profile
Open-Label, Randomized, Parallel-group, Comparative Study of Pharmacokinetics and Bioequivalence of VM-1500FDC (Viriom Ltd, Russia) and Elpida (Viriom Ltd, Russia) and Truvada (Gilead Sciences Ireland UC, UK) When сo-administrated Once Daily Fasting in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2018
Price :
$35
*
At a glance
- Drugs Elsulfavirine/emtricitabine/tenofovir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Viriom
- 29 Oct 2018 Status changed from recruiting to completed.
- 25 Oct 2018 New trial record